Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS. Zivadinov R, Bergsland N, Hagemeier J, Ramasamy DP, et al. Neurology 2019;93:e611-e623.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zivadinov R, Bergsland N, Hagemeier J, Ramasamy DP, et al. Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS. Neurology 2019;93:e611-e623.
PMID: 31285398